期刊
MEDCHEMCOMM
卷 10, 期 8, 页码 1242-1255出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c9md00195f
关键词
-
资金
- French Agence Nationale de la Recherche [ANR-11-JS07-011-01, ANR-17-CE18-0009]
- Fondation ARC
- Agence Nationale de la Recherche (ANR) [ANR-17-CE18-0009] Funding Source: Agence Nationale de la Recherche (ANR)
RNA is one of the most intriguing and promising biological targets for the discovery of innovative drugs in many pathologies and various biologically relevant RNAs that could serve as drug targets have already been identified. Among the most important ones, one can mention prokaryotic ribosomal RNA which is the target of several marketed antibiotics, viral RNAs or oncogenic microRNAs that are tightly involved in the development and progression of various cancers. Oligonucleotides are efficient and specific RNA targeting agents but suffer from poor pharmacodynamic and pharmacokinetic properties. For this reason, a number of synthetic small-molecule ligands have been identified and studied upon screening of chemical libraries or focused design of RNA binders. In this review, we report the most relevant examples of synthetic compounds bearing sufficient selectivity to envisage clinical studies and future therapeutic applications with a particular attention for the main strategies that can be undertaken toward the improvement of selectivity and biological activity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据